KNOWLEDGE / Publication / POST
September 16, 2021
Abstract:

Scientific Poster presented on September 2021 at International Parkinson and Movement Disorder Society.

Objective:

This study aimed at developing an automated rating method for the MDS-UPDRS motor scores in Parkinson’s disease (PD) patients. This automated rating uses inertial measurement units (IMUs) to assist in the motor examination of the MDS-UPDRS. 

Background:

In PD, the gold standard to evaluate the severity of the motor and non-motor symptoms is the MDS-UPDRS. However, the precision of the PD motor signs evaluation remains constrained by subjectivity and inter-examiner variability. A more objective assessment method may decrease or even eliminate these limitations. 

Methods 

PD Study:

Tools4Patient has developed an IMU-based device where sensors are placed on the tip of the index finger and thumb bilaterally. The device was used in a PD study to record movements during 4 motor tasks of the MDS-UPDRS Part III: finger tapping (FT), pronation/supination of hands (PSH), postural tremor of the hands (PTH) and kinetic tremor of the hands (KTH). This pilot study including 14 PD subjects was single-site, non-randomized, observational with no treatment intervention.  

Modeling:

Features quantifying the movement were extracted for each task using IMU-recordings. From these features, a machine-learning model estimated the MDS-UPDRS motor scores of patients. The performance of this automated scoring method was evaluated with the concordance index (C-index) measuring the concordance with the scores given by one MDS-UPDRS certified examiner. 

Results: 

The performances of the automated scoring method were significant for the four targeted tasks: FT, PSH, PTH, and KTH. The C-Indices were 0.803, 0.772, 0.892 and 0.798, respectively, with all the p-values below 0.001. 

To put these results into perspective, we estimated the concordance between several MDS-UPDRS certified examiners evaluating the same motor tasks using video recordings of patients. Their concordance was similar or lower to the concordance of the automated rating method. 

Conclusions:

Tools4Patient has developed an IMU-based device combined with machine-learning models to automatically, accurately, and objectively measure the MDS-UPDRS hand motor scores (FT, PSH, PTH and KTH tasks) when compared with more subjective examiner assessments. This automated rating may help assess motor tasks in PD patients with greater accuracy. This method might eventually be improved to provide motor scores on a continuous scale.

Type:
Scientific Poster
Authors:
Marchal S., Garraux G., Branders S., Bernard G., Billocq C., Pereira A.
Date:
September 17, 2021
Conference:
International Parkinson and Movement Disorder Society
File:

Authors

Related content

Publication

Correcting For The Individual Patient Regression To The Mean Effect

Often, the primary endpoint of RCTs is defined as a change from baseline of a continuous outcome. In…

Type: Scientific Poster
Authors: Samuel Branders, PhD; Guillaume Bernard, PhD; Alvaro Pereira, PhD
Conference: American Society for Clinical Pharmacology and Therapeutics
Read More
Publication

Do Environmental Parameters Influence The Prediction Of The Placebo Response?

This proof-of-concept study on peripheral neuropathic pain patients investigates the potential influence of the investigator on the placebo…

Read More
Publication

Bayesian Modeling Of The Placebo Response In Neuropathic Pain

In analgesia randomized clinical trials (RCTs), the magnitude and the variability of the placebo response have a negative…

Type: Scientific Poster
Authors: Samuel Branders, PhD; Alvaro Pereira, PhD; Frederic Clermont, PhD; Chantal Gossuin; Dominique Demolle, PhD
Conference: Promoting Statistical Insight Conference
Read More

The next frontier in clinical research & patient management

We’re proud to be leading the charge into the next era of drug development.
Cognivia helps clinical trials reduce data variability, empower decision-making, and accelerate the launch of new therapies.
Tell us about your clinical trial below and we’ll be in touch.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.